NSAC votes to grant Chael Sonnen a TUE for UFC 148
Chael Sonnen’s positive test after UFC 117 (a T/E ratio of 16.9 to 1) has been the most famous case…
Chael Sonnen’s positive test after UFC 117 (a T/E ratio of 16.9 to 1) has been the most famous case of Testosterone Replacement Therapy (TRT) misconduct in the UFC to date.
On May 21st, 2012, the Nevada State Athletic Commission set up a hearing on a wide range of issues. 27th on the agenda, was Chael Sonnen’s hearing to apply for a Theraputic Use Exemption (TUE) for TRT. The exemption is a crucial part of Sonnen’s license application for UFC 148 in Las Vegas.
After a lengthy discussion on TUE policies in Nevada, the commission called upon Sonnen and began the hearing. Chael was asked to explain his failure to record his TRT use prior to UFC 117. Using a plausible deniability excuse, Sonnen explained that his old manager was responsible for handling his paperwork and that he was unaware of his mistakes.
After a short deliberation, a quick motion led to a unanimous vote in favour of offering Chael Sonnen TUE for Testosterone Replacement Therapy for his upcoming bout against Anderson Silva at UFC 148. The license comes with the conditions that Sonnen undergoes several pre/post fight blood tests as well as present his Illinois and Texas exemption papers from 2010.
Sonnen was also offered an advisory capacity position to work alongside Director Keith Kizer to improve TRT policies in Nevada.
UFC 148 takes place July 7th at the MGM Grand Garden Arena in Las Vegas, Nevada.